MoneySeptember 2, 2026via GeekWire
NewDays brings its AI-driven dementia care platform to Nevada, expands seed round to $16M
Why it matters
A healthcare AI startup is moving from pilot to regional scale with fresh capital, signaling investor confidence in AI-assisted clinical workflows and the emergence of a new category: AI companions embedded in telehealth platforms for chronic disease management.
Key signals
- Seed round expanded to $16M
- AI companion product named 'Sunny' for mild dementia treatment
- Early research shows up to 18 months of cognitive preservation
- Expansion across six states, including Nevada
- Model combines telehealth clinicians with AI
- Seattle-based startup
- Seed round: $16M
- Company: NewDays (Seattle startup)
- AI product: Sunny (companion for dementia care)
- Clinical outcome: up to 18 months of cognitive function preservation
- Expansion: six states, now including Nevada
- Model: telehealth clinicians + AI companion (hybrid)
The hook
$16M. That's what NewDays just raised to scale its AI companion for dementia care across six states.
Seattle startup NewDays raised $16 million to scale its combination of telehealth clinicians and an AI companion named Sunny for treating mild dementia. Early research shows the platform can help preserve cognitive function by up to 18 months, and the company is now expanding across six states.